Open Access

AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells

Octavio Galindo-Hernández

Octavio Galindo-Hernández

Facultad de Medicina Mexicali, Universidad Autónoma de BajaCalifornia,
Search for this author on
Sciendo|Google Scholar
Galindo-Hernández, Octavio
 and 
José Luis Vique-Sánchez

José Luis Vique-Sánchez

Facultad de Medicina Mexicali, Universidad Autónoma de BajaCalifornia,
Search for this author on
Sciendo|Google Scholar
Vique-Sánchez, José Luis
  
Apr 13, 2022
AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Apr 13, 2022
Page range: 329 - 343
Accepted: Oct 18, 2021
DOI: https://doi.org/10.2478/acph-2022-0024
Keywords
© 2022 Octavio Galindo-Hernández et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Galindo-Hernández, Octavio
Facultad de Medicina Mexicali, Universidad Autónoma de BajaCalifornia
Vique-Sánchez, José Luis
Facultad de Medicina Mexicali, Universidad Autónoma de BajaCalifornia
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, Pharmacy, other
Journal RSS Feed